456 related articles for article (PubMed ID: 26400031)
21. Macrophage activation syndrome and cytokine-directed therapies.
Schulert GS; Grom AA
Best Pract Res Clin Rheumatol; 2014 Apr; 28(2):277-92. PubMed ID: 24974063
[TBL] [Abstract][Full Text] [Related]
22. [Macrophage activation syndrome in a patient with systemic juvenile idiopathic arthritis].
Tavares AC; Ferreira GA; Guimarães LJ; Guimarães RR; Santos FP
Rev Bras Reumatol; 2015; 55(1):79-82. PubMed ID: 25575650
[TBL] [Abstract][Full Text] [Related]
23. [Macrophage activation syndrome: report on three cases].
Zietkiewicz M; Hajduk A; Wojteczek A; Smoleńska Z; Czuszyńska Z; Zdrojewski Z
Ann Acad Med Stetin; 2012; 58(1):55-61. PubMed ID: 23547396
[TBL] [Abstract][Full Text] [Related]
24. Mouse models of systemic juvenile idiopathic arthritis and macrophage activation syndrome.
Inoue N; Schulert GS
Arthritis Res Ther; 2023 Mar; 25(1):48. PubMed ID: 36964620
[TBL] [Abstract][Full Text] [Related]
25. Macrophage activation syndrome in systemic lupus erythematosus and systemic-onset juvenile idiopathic arthritis: a retrospective study of similarities and dissimilarities.
Naveen R; Jain A; Muhammed H; Gupta L; Misra DP; Lawrence A; Agarwal V; Misra R; Aggarwal A
Rheumatol Int; 2021 Mar; 41(3):625-631. PubMed ID: 33388903
[TBL] [Abstract][Full Text] [Related]
26. Heterogeneity of macrophage activation syndrome and treatment progression.
Dong Y; Wang T; Wu H
Front Immunol; 2024; 15():1389710. PubMed ID: 38736876
[TBL] [Abstract][Full Text] [Related]
27. Secondary hemophagocytic lymphohistiocytosis and severe sepsis/ systemic inflammatory response syndrome/multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation.
Castillo L; Carcillo J
Pediatr Crit Care Med; 2009 May; 10(3):387-92. PubMed ID: 19325510
[TBL] [Abstract][Full Text] [Related]
28. Diagnosing haemophagocytic syndrome.
Sen ES; Steward CG; Ramanan AV
Arch Dis Child; 2017 Mar; 102(3):279-284. PubMed ID: 27831908
[TBL] [Abstract][Full Text] [Related]
29. Macrophage activation syndrome in children with Kawasaki disease: diagnostic and therapeutic approaches.
Han SB; Lee SY
World J Pediatr; 2020 Dec; 16(6):566-574. PubMed ID: 32418074
[TBL] [Abstract][Full Text] [Related]
30. The role of interleukin-18 in the diagnosis and monitoring of hemophagocytic lymphohistiocytosis/macrophage activation syndrome - a systematic review.
Krei JM; Møller HJ; Larsen JB
Clin Exp Immunol; 2021 Feb; 203(2):174-182. PubMed ID: 33128796
[TBL] [Abstract][Full Text] [Related]
31. Macrophage activation syndrome associated with griscelli syndrome type 2: case report and review of literature.
Sefsafi Z; Hasbaoui BE; Kili A; Agadr A; Khattab M
Pan Afr Med J; 2018; 29():75. PubMed ID: 29875956
[TBL] [Abstract][Full Text] [Related]
32. Macrophage activation syndrome as a complication of juvenile rheumatoid arthritis.
An Q; Jin MW; An XJ; Xu SM; Wang L
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(19):4322-4326. PubMed ID: 29077164
[TBL] [Abstract][Full Text] [Related]
33. [Hemophagocytic lymphohistiocytosis and macrophage activation syndrome : A multidisciplinary challenge].
Ruffer N; Kosch R; Weisel K; Kötter I; Krusche M
Z Rheumatol; 2024 Jun; 83(5):376-386. PubMed ID: 38267764
[TBL] [Abstract][Full Text] [Related]
34. Macrophage activation syndrome in the era of biologic therapy.
Grom AA; Horne A; De Benedetti F
Nat Rev Rheumatol; 2016 May; 12(5):259-68. PubMed ID: 27009539
[TBL] [Abstract][Full Text] [Related]
35. Macrophage activation syndrome: a frequent but under-diagnosed complication associated with rheumatic diseases.
Tristano AG
Med Sci Monit; 2008 Mar; 14(3):RA27-36. PubMed ID: 18301366
[TBL] [Abstract][Full Text] [Related]
36. Macrophage Activation-Like Syndrome: A Distinct Entity Leading to Early Death in Sepsis.
Karakike E; Giamarellos-Bourboulis EJ
Front Immunol; 2019; 10():55. PubMed ID: 30766533
[TBL] [Abstract][Full Text] [Related]
37. Thrombotic Microangiopathy Associated with Macrophage Activation Syndrome: A Multinational Study of 23 Patients.
Minoia F; Tibaldi J; Muratore V; Gallizzi R; Bracaglia C; Arduini A; Comak E; Vougiouka O; Trauzeddel R; Filocamo G; Mastrangelo A; Micalizzi C; Kasapcopur O; Unsal E; Kitoh T; Tsitsami E; Kostik M; Schmid JP; Prader S; Laube G; Maritsi D; Jelusic M; Shenoi S; Vastert S; Ardissino G; Cron RQ; Ravelli A;
J Pediatr; 2021 Aug; 235():196-202. PubMed ID: 33836183
[TBL] [Abstract][Full Text] [Related]
38. The role of IL-1 inhibition in systemic juvenile idiopathic arthritis: current status and future perspectives.
Toplak N; Blazina Š; Avčin T
Drug Des Devel Ther; 2018; 12():1633-1643. PubMed ID: 29922038
[TBL] [Abstract][Full Text] [Related]
39. Intravenous anakinra for the treatment of haemophagocytic lymphohistiocytosis/macrophage activation syndrome: A systematic review.
Charlesworth JEG; Kavirayani A
Eur J Haematol; 2023 Sep; 111(3):458-476. PubMed ID: 37344166
[TBL] [Abstract][Full Text] [Related]
40. Macrophage activation syndrome in a newborn: report of a case associated with neonatal lupus erythematosus and a summary of the literature.
Heijstek V; Habib M; van der Palen R; van Doorn R; Muller PH
Pediatr Rheumatol Online J; 2021 Feb; 19(1):13. PubMed ID: 33568193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
